Download by
Scanning QR Code
No Stock Yet
No Data
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
GainersRevelation Biosciences, Inc. (NASDAQ:REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical stu
Journey Medical Earnings Perspective: Return On Capital Employed
According to data from Benzinga Pro, during Q1, Journey Medical's (NASDAQ:DERM) reported sales totaled $23.30 million. Despite a 93.66% increase in earnings, the company posted a loss of $1.38 million
Journey Medical, Padagis US Reach Settlement Agreement for Qbrexza, Amzeeq, Zilxi Patent Exclusivity
10:00 AM EDT, 05/24/2022 (MT Newswires) -- Journey Medical Corporation (DERM) said Tuesday that it has reached an agreement with Padagis US to settle the patents covering Qbrexza for the treatment of
Journey Medical Announces Settlement Pertaining To QBREXZA, AMZEEQ And ZILXI Patent Exclusivity; Says 'Padagis will not be allowed to launch generic versions of QBREXZA, AMZEEQ and ZILXI until August 15, 2030, July 1, 2031 and April 1, 2027, respectively'
Journey Medical Corporation (NASDAQ:DERM) ("Journey Medical" or the "Company"), a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical produc
Journey Medical Corporation Announces Settlement Agreements Pertaining to QBREXZA®, AMZEEQ® and ZILXI® Patent Exclusivity
SCOTTSDALE, Ariz., May 24, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ:DERM) ("Journey Medical" or the "Company"), a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical produc
Journey Medical Corporation to Present at the B. Riley Securities 22nd Annual Institutional Investor Conference
SCOTTSDALE, Ariz., May 23, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical") (NADSAQ: DERM), a commercial-stage pharmaceutical company that focuses on the development and comm
66 Biggest Movers From Friday
Gainers GeoVax Labs, Inc. (NASDAQ:GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.Leju Holdings Limited (NYSE:LEJU
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public compan
Entera Bio Board Member, Miranda Toledano To Assume CFO Role
Entera Bio Ltd. (NASDAQ:ENTX), a leader in the development of orally delivered large molecule therapeutics, today announced the appointment of Miranda Toledano, one of Entera's existing board members,
Journey Medical price target lowered to $10 from $14 at B. Riley
B. Riley analyst Kalpit Patel lowered the firm's price target on Journey Medical to $10 from $14 and keeps a Buy rating on the shares post the Q1 results. While Journey's strategy will pay dividends i
Loading...
No Stock Yet